Search results for: 'next generation diagnostic market'
- Related search terms
- Next-Generation 911—The Future of Public Safety, Forecast to 2023
- marketing strategy hotel industry year 1999
- Next Generation 911: The Future of Public Safety—Forecast to 2026
- Next Generation 911: The Future of Public Safety-Forecast to 2027
- marketing strategy homes industry year 16.9
-
03 Apr 2023  |  Global  |  Market Outlook
Global Next generation Diagnostics, Outlook 2023
Automation and Digitization Drive the Next Growth Phase Post-COVID-19
As COVID-19 transitions to the endemic phase, automation solutions and smart, connected laboratories will catalyze recovery in the next-generation diagnostics industry. The COVID-19 pandemic left a lot of installed capacity in laboratories and healthcare centers. To take advantage of this situation, it is necessary for industry players to focus on ...
$4,950.00
Special Price $3,712.50 save 25 %
-
21 May 2026  |  Global  |  Market Research
Global Molecular Diagnostic Market—Opportunities and Growth Indicators
Unlocking Growth Through Early Disease Detection, Personalized Therapies, and Global Testing Expansion
The molecular diagnostics industry is undergoing consolidation, requiring capital investment and faster regulatory pathways to accelerate clinical adoption. Major diagnostics and life sciences companies are acquiring proprietary testing platforms to strengthen positions in precision oncology and blood-based diagnostics. AI-enabled genomic workflow ...
$2,450.00 -
28 Jan 2026  |  Global  |  Market Research
OEM Strategies on Next Generation Electric Vehicles, Global, 2025–2031
The Global Electric Vehicle Market is Experiencing Transformational Growth due to OEMs’ Adoption of Universal Platforms to Build the Next Generation of Electric Vehicles
The global electric vehicle (EV) market is undergoing a transformative shift driven by geopolitics, regulations, innovative business models, technology, net-zero targets, and evolving consumer preferences. Supply chain security has been a major challenge in the global EV market, with persistent disruptions from semiconductor shortages, geopolitical...
$4,950.00 -
26 Aug 2024  |  Global  |  Market Research
Growth Opportunities in the Tissue Diagnostics Industry, Global, 2024 2029
Companion Diagnostics-specific Advanced Staining and Multiomics Capabilities are Driving Market Growth
The global tissue diagnostics market will experience significant growth driven by the need for advanced staining in precise biomarker identification in personalized medicine, tissue biopsy test volumes, and pre-analytical and advanced staining platform development. According to the WHO, there will be a 60% rise in cancer cases worldwide by 2040,...
$4,950.00
Special Price $4,207.50 save 15 %
-
09 Jul 2025  |  Global  |  Market Outlook
Global Clinical Diagnostics Outlook, 2025
Driven by Novel Biomarkers, Digital Services, and Automation, Industry is Accelerating Precision, Efficiency, and Early Disease Detection in Molecular Diagnostics and Point-of-care Testing (POCT)
The global clinical diagnostics market is poised for strong growth as stakeholders shift focus toward high-growth segments such as precision medicine, decentralized diagnostics, software-driven solutions, and product expansion. Companies continue to adopt LIMS and other digital platforms while emerging opportunities in the POCT sector further drive...
$4,950.00
Special Price $4,455.00 save 10 %
-
22 Apr 2024  |  Global  |  Market Research
Global Molecular Diagnostics Market, Forecast to 2029
Molecular Diagnostics Unleash Growth Opportunities, Steering Innovation Personalized Medicine
The global molecular diagnostic market will experience significant growth due to a broad range of factors, such as increased demand from the COVID-19 pandemic, an increasing number of cancer cases, and the swift evolution of technological capabilities. Technological advancements, such as polymerase chain reaction (PCR), digital PCR, and next-gen...
$4,950.00
Special Price $3,712.50 save 25 %
-
25 Mar 2026  |  Global  |  Market Research
Global Clinical Diagnostics Industry Growth Opportunities, 2026–2031
Next-Gen AI-Integrated Biomarkers and Smart Automation are Advancing Precision and Early Detection in Molecular and Point-of-Care Diagnostics
The global clinical diagnostics market is poised for strong growth, driven by increased adoption of advanced diagnostics technologies, greater investment in laboratories, and improved access to molecular and immunodiagnostic testing facilities. In 2025, the industry continued its transformation, establishing testing systems as intelligent systems...
$4,950.00 -
14 Jul 2023  |  Global  |  Market Research
Global Next-generation Firewall—Forecast to 2027
Cloud Adoption Dictates Future Growth Potential of Global NGFW
Much like conventional firewalls, next-generation firewalls (NGFWs) filter network traffic based on predetermined security rules but have evolved to include granular application-layer visibility and control capabilities, enabling organizations to examine data traffic more deeply. With the traditional security perimeter of organizations slowly disap...
$4,950.00
Special Price $3,712.50 save 25 %
-
18 Apr 2024  |  Global  |  Market Outlook
Global Clinical Diagnostics Outlook, 2024
Driven by Digital Services and Automation, the Molecular Diagnostics and POCT Sectors Rebound after the COVID-19 Pandemic
With the end of the COVID-19 pandemic, healthcare providers have been directing most of their capabilities toward preventive healthcare and precision medicine, as the clinical diagnostics industry continues its transition from a centralized to a decentralized testing model. Globally, 2024 is set to be a profitable year for the industry, which will ...
$4,950.00
Special Price $3,712.50 save 25 %
-
25 Aug 2026  |  Global  |  Technology Research
Breakthrough Innovations in Point-of-Care Diagnostics
Rapid Molecular Platforms, AI-Powered Workflows, Home-Based Testing, and Connected Care Models to Drive Decentralized Diagnostics
This research analyzes how point-of-care (PoC) diagnostics is evolving from simple tests to decentralized, connected, and clinically actionable testing platforms across hospitals, outpatient settings, homes, and pharmacies.The study assesses key technology shifts, including rapid molecular testing, lateral flow assays, microfluidics, biosensors, sm...
$4,950.00